269 related articles for article (PubMed ID: 12008913)
1. Delivery of dangerous goods: type III secretion in enteric pathogens.
Zaharik ML; Gruenheid S; Perrin AJ; Finlay BB
Int J Med Microbiol; 2002 Mar; 291(8):593-603. PubMed ID: 12008913
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol binding by the bacterial type III translocon is essential for virulence effector delivery into mammalian cells.
Hayward RD; Cain RJ; McGhie EJ; Phillips N; Garner MJ; Koronakis V
Mol Microbiol; 2005 May; 56(3):590-603. PubMed ID: 15819617
[TBL] [Abstract][Full Text] [Related]
3. Salmonella type III secretion effectors: pulling the host cell's strings.
Schlumberger MC; Hardt WD
Curr Opin Microbiol; 2006 Feb; 9(1):46-54. PubMed ID: 16406778
[TBL] [Abstract][Full Text] [Related]
4. Host Cell Targeting by Enteropathogenic Bacteria T3SS Effectors.
Pinaud L; Sansonetti PJ; Phalipon A
Trends Microbiol; 2018 Apr; 26(4):266-283. PubMed ID: 29477730
[TBL] [Abstract][Full Text] [Related]
5. Shigella spp. and enteroinvasive Escherichia coli pathogenicity factors.
Parsot C
FEMS Microbiol Lett; 2005 Nov; 252(1):11-8. PubMed ID: 16182469
[TBL] [Abstract][Full Text] [Related]
6. Yersinia's stratagem: targeting innate and adaptive immune defense.
Heesemann J; Sing A; Trülzsch K
Curr Opin Microbiol; 2006 Feb; 9(1):55-61. PubMed ID: 16413818
[TBL] [Abstract][Full Text] [Related]
7. Type III secretion machines and the pathogenesis of enteric infections caused by Yersinia and Salmonella spp.
Lee VT; Schneewind O
Immunol Rev; 1999 Apr; 168():241-55. PubMed ID: 10399078
[TBL] [Abstract][Full Text] [Related]
8. Invasive enteric pathogens.
Formal SB; Hale TL; Sansonetti PJ
Rev Infect Dis; 1983; 5 Suppl 4():S702-7. PubMed ID: 6356290
[TBL] [Abstract][Full Text] [Related]
9. Effects of subtherapeutic concentrations of antimicrobials on gene acquisition events in Yersinia, Proteus, Shigella, and Salmonella recipient organisms in isolated ligated intestinal loops of swine.
Brewer MT; Xiong N; Anderson KL; Carlson SA
Am J Vet Res; 2013 Aug; 74(8):1078-83. PubMed ID: 23879845
[TBL] [Abstract][Full Text] [Related]
10. Shigella IpaH Family Effectors as a Versatile Model for Studying Pathogenic Bacteria.
Ashida H; Sasakawa C
Front Cell Infect Microbiol; 2015; 5():100. PubMed ID: 26779450
[TBL] [Abstract][Full Text] [Related]
11. Site-specific incorporation of photo-cross-linker and bioorthogonal amino acids into enteric bacterial pathogens.
Lin S; Zhang Z; Xu H; Li L; Chen S; Li J; Hao Z; Chen PR
J Am Chem Soc; 2011 Dec; 133(50):20581-7. PubMed ID: 22084898
[TBL] [Abstract][Full Text] [Related]
12. Cellular mechanisms of bacterial internalization counteracted by Yersinia.
Fällman M; Gustavsson A
Int Rev Cytol; 2005; 246():135-88. PubMed ID: 16164968
[TBL] [Abstract][Full Text] [Related]
13. Host cell death due to enteropathogenic Escherichia coli has features of apoptosis.
Crane JK; Majumdar S; Pickhardt DF
Infect Immun; 1999 May; 67(5):2575-84. PubMed ID: 10225923
[TBL] [Abstract][Full Text] [Related]
14. Type iii protein secretion in yersinia species.
Ramamurthi KS; Schneewind O
Annu Rev Cell Dev Biol; 2002; 18():107-33. PubMed ID: 12142275
[TBL] [Abstract][Full Text] [Related]
15. [Influence of human gastrointestinal tract bacterial pathogens on host cell apoptosis].
Wronowska W; Godlewska R; Jagusztyn-Krynicka EK
Postepy Biochem; 2005; 51(3):270-9. PubMed ID: 16381171
[TBL] [Abstract][Full Text] [Related]
16. Biochemical functions of Yersinia type III effectors.
Shao F
Curr Opin Microbiol; 2008 Feb; 11(1):21-9. PubMed ID: 18299249
[TBL] [Abstract][Full Text] [Related]
17. Shigella and Enteroinvasive Escherichia Coli.
Belotserkovsky I; Sansonetti PJ
Curr Top Microbiol Immunol; 2018; 416():1-26. PubMed ID: 30218158
[TBL] [Abstract][Full Text] [Related]
18. The molecular evolutionary history of Shigella spp. and enteroinvasive Escherichia coli.
Peng J; Yang J; Jin Q
Infect Genet Evol; 2009 Jan; 9(1):147-52. PubMed ID: 19000785
[TBL] [Abstract][Full Text] [Related]
19. Enteropathogenic Escherichia coli (EPEC) Tir receptor molecule does not undergo full modification when introduced into host cells by EPEC-independent mechanisms.
Kenny B; Warawa J
Infect Immun; 2001 Mar; 69(3):1444-53. PubMed ID: 11179311
[TBL] [Abstract][Full Text] [Related]
20. Salmonella and Shigella species.
Edwards BH
Clin Lab Med; 1999 Sep; 19(3):469-87, v. PubMed ID: 10549421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
